🔎 Trials Near Me

Home › Amyotrophic Lateral Sclerosis › Maryland

Pag-aaral pangklinika para sa Amyotrophic Lateral Sclerosis sa Maryland

16 pag-aaral para sa Amyotrophic Lateral Sclerosis ang naghahanap ng mga kalahok sa mga site sa Maryland.

Mga Lungsod sa Maryland

Opisyal na teksto ng pag-aaral (English)

Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 1
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07204977

A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)

  • USA003, Baltimore
Nagre-recruitPhase 1
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07290062

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

  • Johns Hopkins University, Baltimore
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07322003

Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

  • National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT03225144

Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body Myositis

  • The Johns Hopkins Hospital, Baltimore
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07823101

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Sunstone Therapies, PC, Rockville
  • Sheppard Pratt, Towson
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07002034

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)

  • Johns Hopkins Medicine, Baltimore
Nagre-recruit
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07521930

ASSESS ALL ALS Study

  • John Hopkins University, Baltimore
  • Nih/Ninds, Bethseda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT06578195

PREVENT ALL ALS Study

  • John Hopkins University, Baltimore
  • Nih/Ninds, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT06581861

Investigation on the Cortical Communication (CortiCom) System

  • Johns Hopkins Medicine, Baltimore
Nagre-recruit
Edad 22 hanggang 70 · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT03567213

Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis

  • Johns Hopkins Center for Psychedelic and Consciousness Research, Baltimore
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT06656702

Study of COYA 302 for the Treatment of ALS

  • Johns Hopkins, Baltimore
Nagre-recruitPhase 2/3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07161999

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

  • Johns Hopkins University, Baltimore
  • NIH, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT04363684

Impact of Physical Functioning on Patient-Reported Outcomes in ALS Patients at TidalHealth

  • TidalHealth Peninsula Regional, Inc., Salisbury
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT07491484

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis

  • Pharmaron, Inc., Baltimore
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Mar 5, 2026 · NCT07221240

Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

  • Johns Hopkins Medicine Brain Science Institute, Baltimore
Nagre-recruitPhase 3
Edad 18 hanggang 81 · Lahat ng kasarian · Na-update Set 12, 2025 · NCT03127267

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.